Advertisement
Screener

Foamix Pharmaceuticals Ltd. Forms 3, 4 and 5: Warrants

Foamix Pharmaceuticals Ltd. Forms 3, 4 and 5: Warrants

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2019-08-06: Reporting owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | EDELMAN JOSEPH | PERCEPTIVE ADVISORS LLC; Form 3; Security Warrants (right to buy); Transaction Holding.
  • 2018-05-13: Reporting owner Hirsch Stanley; Form 4; Security Warrants (right to buy); Transaction X Exercise of in-the-money or at-the-money derivative security.
  • 2018-01-18: Reporting owner Eini Meir; Form 3; Security Warrants; Transaction Holding.
  • 2018-01-11: Reporting owner Hirsch Stanley; Form 3; Security Warrants; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2019-08-06
holding as of filing
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | EDELMAN JOSEPH | PERCEPTIVE ADVISORS LLC
10% Owner | 10% Owner | 10% Owner
3Warrants (right to buy)
Derivative · Indirect · See footnote
Holding$2.09
exercise price
2019-08-06
2018-05-13Hirsch Stanley
Director
4Warrants (right to buy)
Derivative · Direct
X Exercise of in-the-money or at-the-money derivative security−6,224
0 owned after
$5.04
exercise price
2018-05-31
2018-01-18
holding as of filing
Eini Meir
Other (Observer to Board of Directors)
3Warrants
Derivative · Indirect · (m)
Holding$5.04
exercise price
2018-01-18
2018-01-11
holding as of filing
Hirsch Stanley
3Warrants
Derivative · Direct · (m)
Holding$5.04
exercise price
2018-01-11
2018-01-11
holding as of filing
Tamarkin Dov
Director
3Warrants
Derivative · Indirect · (m)
Holding$5.04
exercise price
2018-01-11